Cesare Cremon1, Marilia Carabotti2, Rosario Cuomo3, Fabio Pace4, Paolo Andreozzi3, Maria Raffaella Barbaro1, Bruno Annibale2, Giovanni Barbara1. 1. Department of Medical and Surgical Sciences, Centre for Applied Biomedical Research, University of Bologna, Bologna, Italy. 2. Medical-Surgical Department of Clinical Sciences and Translational Medicine, University Sapienza, Rome, Italy. 3. Sant'Anna and San Sebastiano Hospital, Gastroenterology and Digestive Endoscopy Unit, Caserta, Italy. 4. Unit of Gastroenterology, "Bolognini" Hospital, Bergamo, Italy.
Abstract
Background: Although diverticular disease is a common condition, its effective treatment is challenging in clinical practice. Objective: The objective of this article is to assess pharmacological management in different clinical settings of diverticular disease and factors associated with treatment using the Italian registry Registro Malattia Diverticolare (REMAD). Methods: At study enrolment, patients were categorised into subgroups: diverticulosis, symptomatic uncomplicated diverticular disease and previous diverticulitis. We registered demographic, clinical and lifestyle factors, quality of life and the use of treatments for diverticular disease in the last year. Logistic regression analysis assessed the association between clinical factors and treatment consumption. Results: A total of 500 of the 1206 individuals included had had at least one treatment for diverticular disease in the last year: 23.6% (166/702) of patients with diverticulosis, 55.9% (165/295) of patients with symptomatic diverticular disease, and 80.9% (169/209) of patients with previous diverticulitis (p < 0.001). In multivariate analysis, the following factors were significantly associated with treatment use: female gender, family history of colonic diverticula, organic digestive comorbidity and impaired physical quality of life components. Conclusion: Individuals with diverticular disease take medications based on the different clinical settings of disease. We identified different features associated with treatment use in the distinct clinical entities of diverticular disease.ClinicalTrial.gov Identifier: NCT03325829.
Background: Although diverticular disease is a common condition, its effective treatment is challenging in clinical practice. Objective: The objective of this article is to assess pharmacological management in different clinical settings of diverticular disease and factors associated with treatment using the Italian registry Registro Malattia Diverticolare (REMAD). Methods: At study enrolment, patients were categorised into subgroups: diverticulosis, symptomatic uncomplicated diverticular disease and previous diverticulitis. We registered demographic, clinical and lifestyle factors, quality of life and the use of treatments for diverticular disease in the last year. Logistic regression analysis assessed the association between clinical factors and treatment consumption. Results: A total of 500 of the 1206 individuals included had had at least one treatment for diverticular disease in the last year: 23.6% (166/702) of patients with diverticulosis, 55.9% (165/295) of patients with symptomatic diverticular disease, and 80.9% (169/209) of patients with previous diverticulitis (p < 0.001). In multivariate analysis, the following factors were significantly associated with treatment use: female gender, family history of colonic diverticula, organic digestive comorbidity and impaired physical quality of life components. Conclusion: Individuals with diverticular disease take medications based on the different clinical settings of disease. We identified different features associated with treatment use in the distinct clinical entities of diverticular disease.ClinicalTrial.gov Identifier: NCT03325829.
Authors: R Pezzilli; A M Morselli-Labate; L Frulloni; G M Cavestro; B Ferri; G Comparato; L Gullo; R Corinaldesi Journal: Dig Liver Dis Date: 2005-10-19 Impact factor: 4.088
Authors: M Bianchi; V Festa; A Moretti; A Ciaco; M Mangone; V Tornatore; A Dezi; R Luchetti; B De Pascalis; C Papi; M Koch Journal: Aliment Pharmacol Ther Date: 2011-03-02 Impact factor: 8.171
Authors: Rosario Cuomo; Giovanni Barbara; Fabio Pace; Vito Annese; Gabrio Bassotti; Gian Andrea Binda; Tino Casetti; Antonio Colecchia; Davide Festi; Roberto Fiocca; Andrea Laghi; Giovanni Maconi; Riccardo Nascimbeni; Carmelo Scarpignato; Vincenzo Villanacci; Bruno Annibale Journal: United European Gastroenterol J Date: 2014-10 Impact factor: 4.623
Authors: Cesare Cremon; Lara Bellacosa; Maria R Barbaro; Rosanna F Cogliandro; Vincenzo Stanghellini; Giovanni Barbara Journal: Minerva Gastroenterol Dietol Date: 2017-01-12
Authors: Giuseppe Comparato; Libera Fanigliulo; Giovanni Aragona; Giulia M Cavestro; Lucas G Cavallaro; Gioacchino Leandro; Alberto Pilotto; Giorgio Nervi; Paolo Soliani; Mario Sianesi; Angelo Franzé; Francesco Di Mario Journal: Dig Dis Date: 2007 Impact factor: 2.404
Authors: Anne F Peery; Evan S Dellon; Jennifer Lund; Seth D Crockett; Christopher E McGowan; William J Bulsiewicz; Lisa M Gangarosa; Michelle T Thiny; Karyn Stizenberg; Douglas R Morgan; Yehuda Ringel; Hannah P Kim; Marco Dacosta DiBonaventura; Charlotte F Carroll; Jeffery K Allen; Suzanne F Cook; Robert S Sandler; Michael D Kappelman; Nicholas J Shaheen Journal: Gastroenterology Date: 2012-08-08 Impact factor: 22.682